EP2004243A2 - Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire - Google Patents

Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire

Info

Publication number
EP2004243A2
EP2004243A2 EP06838801A EP06838801A EP2004243A2 EP 2004243 A2 EP2004243 A2 EP 2004243A2 EP 06838801 A EP06838801 A EP 06838801A EP 06838801 A EP06838801 A EP 06838801A EP 2004243 A2 EP2004243 A2 EP 2004243A2
Authority
EP
European Patent Office
Prior art keywords
plication
tissue
plications
suture
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06838801A
Other languages
German (de)
English (en)
Other versions
EP2004243A4 (fr
Inventor
Thomas Bromander
Amos Cruz
Michael D. Laufer
Ram Chuttani
Jonathan O'keefe
Lynne Haupt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NDO Surgical Inc
Original Assignee
NDO Surgical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NDO Surgical Inc filed Critical NDO Surgical Inc
Publication of EP2004243A2 publication Critical patent/EP2004243A2/fr
Publication of EP2004243A4 publication Critical patent/EP2004243A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552—Details of sensors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876—Blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6879—Means for maintaining contact with the body
    • A61B5/6882—Anchoring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6879—Means for maintaining contact with the body
    • A61B5/6884—Clamps or clips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30—Surgical pincettes without pivotal connections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00827—Treatment of gastro-esophageal reflux
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0404—Buttons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417—T-fasteners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0472—Multiple-needled, e.g. double-needled, instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30—Surgical pincettes without pivotal connections
    • A61B2017/305—Tweezer like handles with tubular extensions, inner slidable actuating members and distal tools, e.g. microsurgical instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/06—Accessories for medical measuring apparatus
    • A61B2560/063—Devices specially adapted for delivering implantable medical measuring apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25—Bioelectric electrodes therefor
    • A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283—Invasive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Definitions

  • the present invention relates to endoluminal surgical devices and methods. More particularly, the devices and methods provide for endoluminal gastric restriction, closure of gastric and/or non-gastric wall openings, treatment of fistulas, tissue reconfiguration, and the like.
  • Laparoscopic surgery has greatly reduced the size and scope of incisions made in a patient and resulted in reduced morbidity and mortality rates.
  • a technique that is developing to further reduce surgical complications is to work through an endoluminal access port.
  • An example of an endoluminal access port is the mouth and this access port can give a surgeon access to a patient's esophagus and stomach.
  • stomach tissue often needs surgical treatment to treat fistulas and to close transgastric incisions to stop stomach fluids from leaking from the stomach to surrounding tissue and to stop infectious matter from spreading from or to the stomach tissue.
  • Other stomach treatments include stomach reduction procedures for obese patients.
  • physicians have been placing devices such as the Lap Band® on the external surface of the gastric wall to create a restricted stomach capacity.
  • Another traditional procedure for stomach reduction includes a laproscopic procedure in which surgeons protrude into the stomach from the exterior of the patient and staple the stomach into a smaller volume. This restriction creates a pouch inside the stomach which fills quickly when food is ingested and assists in generating a sensation of being full.
  • these procedures have drawbacks such as complications from port punctures of the stomach, large incisions, substantial recovery time, expense, lost productive work time, infection, and the like.
  • the incisions created by the current surgical procedures also include a morbidity and mortality rate that can be reduced by reducing or eliminating the need for such incisions by accessing the surgical site endoluminally.
  • an endoluminal implant device includes a tissue anchor implant configured to be implanted into a lumen of a body without creating an incision in integument of the body.
  • the tissue anchor implant is also configured to maintain a plication in a wall of the lumen.
  • a medical treatment associated with the tissue anchor implant includes a drug for delivery within the lumen, a biological stimulation device, or a monitoring device.
  • the biological stimulation device is selected from the group of an electrical stimulation device, mechanical stimulation device, vibratory device, sound device, ultra-sound device, chemical stimulatory device, neuro-transmitter stimulation device, thermal stimulation, sensory stimulatory device, and combinations thereof.
  • the monitoring device is selected from the group of a pH sensor, pressure sensor, chemical sensor, hormone sensor, dilation sensor, fluid sensor, ion sensor, tissue extension sensor, and combinations thereof.
  • the medical treatment includes material selected from the group of radioactive material, chemotherapy material, biological material, small molecule drug material, and combinations thereof.
  • the medical treatment is configured to treat a local gastric condition or a systemic condition.
  • the medical implant includes bioresorbable material.
  • the medical implant is selected from the group of PPI/H2 blockers, pain medication, cardiac medication, antihypertensives agents, insulin, hypoglycemic agents, antipsychotic medications birth control medications, pH sensor with or without antacid secretion, vascular sensor for oxygen, vascular sensor for carbon dioxide, vascular sensor for glucose, vascular sensor for blood pressure, sensor for defibrillation, cardiac rate sensor, cardiac rhythm sensor, medications to stimulate vagus nerve, or the like.
  • an endoscopic treatment method includes introducing an endoluminal device into a lumen of a patient without creating an incision in integument of the patient, engaging a wall of the lumen with an end effecter of the endoluminal device to form a plication, and activating the end effecter to secure the plication with an anchor object and a treatment device, wherein the treatment device is coupled with the anchor object.
  • the treatment device includes a drug delivery device, a biological stimulation device, or is configured to treat a local gastric condition or a systemic medical condition.
  • the treatment device includes material selected from the group of radioactive material, chemotherapy material, biological material, small molecule drug material, and combinations thereof.
  • the treatment device includes a feeding tube, a bioresorbable material, or a drug.
  • the anchor object further includes an attachment device for removably coupling the treatment device.
  • the attachment device is selected from the group of a hook, magnet, loop, and combinations thereof.
  • a non-invasive endosurgical device includes an endoluminal device having a longitudinally extending flexible shaft, a distal end of the longitudinally extending flexible shaft configured to engage tissue to be treated, a needle coupled with the distal end for piercing tissue, and a barb configured on the needle such that tissue pierced with the needle remains on the needle.
  • a distal tip of the needle defines a hole therethrough for receiving suture material or a plurality of holes defined in a distal tip of the needle.
  • the present invention includes suture material looped through the holes in the needle such that the suture material forms the barb or where the suture material extending through the hole is knotted on one side of the hole to form the barb.
  • a non-invasive endosurgical device includes an endoluminal device having a longitudinally extending flexible shaft having a distal end, a first arm and a second arm positioned near the distal end and configured to approximate together and deploy an implant, and a tissue grasper.
  • the tissue grasper includes a longitudinal flexible shaft having a proximal end and a distal end, a handle near the proximal end of the flexible shaft having a slidable member, an inner rod coupled between the slidable member and graspers configured near the distal end and a rigid receiver near the distal end configured to receive the graspers, wherein when a user slides the slidable member proximally the graspers approximate as they are retracted into the rigid receiver.
  • the graspers further include hooks for attaching to tissue to be retracted and can be fabricated from a polymer material, a metal, an alloy, or shape memory metal. In some embodiments, the graspers are about 3.5 cm in length.
  • an endoluminal treatment method includes introducing an endoluminal device into a lumen of a patient without creating an incision in the patient, engaging a wall of the lumen with an end effecter of the endoluminal device, forming a first plication in the wall of the lumen with the end effecter, forming a second plication in the wall of the lumen with the end effecter, the second plication being adjacent the first plication, and coupling the first plication with the second plication to thereby form a first double plication wherein an open pocket is formed between the first plication and the second plication.
  • the plicated tissue is pierced with a needle of the end effecter and retained on the needle.
  • the second plication is pierced with the needle, and an implant is deployed to fix the first plication with the second plication and form the double plication.
  • a second double plication is formed adjacent the first double plication, wherein a second open pocket formed by the second double plication and the open pocked formed by the first double plication are axially aligned.
  • an artificial biological tube if formed by aligning multiple double plications such that open pockets formed by the multiple double plications axially align.
  • the first double plication is coupled with the second double plication.
  • the artificial biological tube is formed in the stomach of a patient and fixes tissue of an anterior wall of the stomach to a posterior wall of the stomach on a lesser curve of the proximal stomach, such that when food passes through the tube and the tube stretches a sensation of fullness or satiety is induced.
  • the 'double plication is positioned near the gastro-esophageal -junction such as to function as an artificial gastric valve.
  • an endoluminal GERD treatment method includes introducing an endoluminal device into a lumen of a patient without creating an incision in the patient and engaging a wall of the lumen with an end effecter of the endoluminal device to form two adjacent plications in the wall of the lumen near the gastro-esophageal -junction such that an artificial biologic tube is formed between the two adjacent plications and distal to the gastro-esophageal-j unction to block gastric fluid from interfering with tissue of the esophagus.
  • a plurality of the two adjacent plications are formed and extend axially from near the gastro-esophageal- junction into the stomach.
  • the artificial biologic tube is between about 0.5 cm and about 5 cm in length or between about 0.5 cm and about 3 cm in diameter.
  • an endoluminal obesity treatment method includes introducing an endoluminal device into a stomach of a patient without creating an incision in the patient and engaging a wall of the stomach with an end effecter of the endoluminal device.
  • two adjacent plications are formed in the wall of the stomach such that an artificial biologic tube is formed between the two adjacent plications to thereby reducing a volume of the stomach to treat obesity.
  • a plurality of the two adjacent plications are formed in the wall of the stomach, wherein the plurality of the two adjacent plications are substantially axially aligned.
  • the plications are positioned distal to the patient's gastro- esophageal-j unction such that a pouch of stomach tissue remains between the gastro- esophageal-j unction and the artificial biologic tube.
  • the artificial biologic tube is between about 0.5 cm and about 10 cm in length, between about 1 cm and about 8 cm in length, between about 0.2 cm and about 5 cm in diameter, and/or between about 0.5 cm and about 3 cm in diameter.
  • the artificial biologic tube if formed by fixing tissue of an anterior wall of the stomach to a posterior wall of the stomach on a lesser curve of the proximal stomach, such that when food passes through the tube and the tube stretches a sensation of fullness or satiety is induced.
  • an endoluminal treatment method includes introducing an endoluminal device into a lumen of a patient through a body cavity, forming a first plication from a first portion of a wall of the lumen by a first manipulation of the endoluminal device, attaching a suture to the first plication, forming a second plication from a second portion of the wall of the lumen by a second manipulation of the endoluminal device, attaching the suture to the second plication, and tightening the suture such that the first plication and the second plication are approximated.
  • the lumen is a lumen of a stomach of the patient and tightening of the suture and approximating the first and second plications reduces a volume within the lumen.
  • the approximated plications augment a gastro-esophageal junction of a stomach of the patient and are positioned in the stomach and between about 2 cm and about 5 cm from the gastro-esophageal junction.
  • the volume of the reduced lumen is between about 5 mL and about 20 mL and in other embodiments, the volume of the reduced lumen is between about 10 mL and about 15 mL.
  • the volume of the reduced lumen has an opening to a remaining portion of the hollow organ of between about 5 mm and about 15 mm in an average cross-sectional dimension.
  • FIG. 1 shows a schematic view of an endoluminal surgical device according to an embodiment of the present invention
  • FIG. 2 shows a schematic view of a tissue engaging end effecter of an endoluminal surgical device according to an embodiment of the present invention
  • FIG. 3 shows an implanted device according to an embodiment of the present invention
  • FIGS. 4A and 4B show implanted devices according to other embodiments of the present invention.
  • FIG. 5 shows an device positioned on an end effecter prior to implantation according to an embodiment of the present invention
  • FIG. 6 shows a tissue plication including an implanted device according to an embodiment of the present invention
  • FIG. 7 shows another device positioned on an end effecter prior to implantation according to an embodiment of the present invention
  • FIG. 8 shows another tissue plication including an implanted device according to an embodiment of the present invention
  • FIG. 9 shows yet device positioned on an end effecter prior to implantation according to an embodiment of the present invention.
  • FIG. 10 shows another tissue plication including an implanted device according to an embodiment of the present invention.
  • FIG. 11 shows an implanted device according to another embodiment of the present invention.
  • FIG. 12 shows an end effecter with a tissue plication formed on a needle of the end effecter according to an embodiment of the present invention
  • FIG. 13 shows an end effecter with multiple tissue plications formed on a needle of the end effecter according to an embodiment of the present invention
  • FIGS. 14A-14C show embodiments of a tissue plication and corresponding open tissue pocket according to embodiments of the present invention
  • FIG. 15 shows a distal end of an endoluminal device according to an embodiment of the present invention
  • FIG. 16 shows another distal end of an endoluminal device according to an embodiment of the present invention.
  • FIG. 17 shows another distal end of an endoluminal device according to an embodiment of the present invention.
  • FIG. 18 shows a suture pusher according to an embodiment of the present invention
  • FIG. 19 shows a cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention.
  • FIG. 20 shows yet another cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention
  • FIG. 21 shows a further cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention.
  • FIG. 22 shows another cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention
  • FIG. 23 shows another cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention
  • FIG. 24 shows another cross-sectional plan view of plications formed within a hollow organ according to an embodiment of the present invention.
  • FIGS. 25 A and 25B show a further cross-sectional plan views of plications formed within a hollow organ according to an embodiment of the present invention
  • FIG. 26 shows a side view of a hollow organ following approximation of plications formed intraluminally according to an embodiment of the present invention
  • FIG. 27 shows a tissue grasper according to an embodiment of the present invention
  • FIG. 28 shows a distal end of a tissue grasper according to an embodiment of the present invention
  • FIG. 29 shows a tissue grasper in association with an end effecter according to an embodiment of the present invention
  • FIG. 30 shows varying embodiments of needles for piercing tissue according to embodiments of the present invention.
  • FIG. 31 shows a needle with suture threaded through distal holes in the needle according to embodiments of the present invention
  • FIG. 32 shows a tissue fixation device implanted on tissue according to embodiments of the present invention
  • FIG. 33 shows a suture clip according to an embodiment of the present invention.
  • FIG. 34 shows another view of a suture clip according to an embodiment of the present invention.
  • the present invention provides methods and devices for manipulate tissue, closing incisions, repairing fistulas, and the like in a hollow organ by accessing the tissue through a body orifice.
  • the tissue of a hollow organ such as for example, the stomach, can be manipulated to generate a fold or plication and a suture based tissue anchoring implant can be implanted to maintain the manipulated character of the tissue.
  • the suture 6 046026 after the tissue is manipulated into several folds or plications, the suture 6 046026
  • a drug or device can also be introduced into the lumen of the organ and implanted or attached to the organ wall with a suture based implant.
  • multiple plications can be linearly aligned with respect to each other such as to form an artificial biological tube.
  • Devices are also disclosed for manipulating the tissue in accord with the methods of the present invention.
  • An endoluminal device 100 such as that shown in FIG. 1 and disclosed in U.S. Patent No's. 6,835,200; 6,821,285; 6,773,441; 6,663,639; 6,506,196; and 6,494,888, and U.S. Published Application No's. 2005/0033328; 2004/0194790; 2004/0193194; 2004/0193193; 2004/0193184; 2004/0193117; 2002/0193816; and U.S. Provisional patent application no. 60/741,510 filed December I 5 2005, the disclosure of each is hereby incorporated by reference in its entirety, is utilized in the present invention to manipulate tissue of a patient.
  • the endoluminal device 100 is configured such that it can be positioned within a hollow organ by entry through a body cavity opening, such as for example, positioning the device into the stomach via the mouth of a patient. Once introduced into the patient, the device is capable of manipulating tissue and implanting objects or devices.
  • Endoluminal surgical device 100 includes a generally longitudinal and flexible shaft 102, an end effecter 200 configured near the distal end of flexible shaft 102, and control mechanisms configured near the proximal end of flexible shaft 102.
  • End effecter 200 shown in FIG. 2, includes first arm 202 and second arm 204.
  • First arm 202 and second arm 204 are configured to engage tissue and implant anchor object 220.
  • anchor object 220 generally includes pledgets 222 and 224 which, according to some embodiments, are connected by suture 226.
  • first arm 202 and second arm 204 are positioned with respect to tissue that is to be manipulated. The arms are manipulated by actuating controls on proximal end 104 of endoluminal surgical device 100.
  • end effecter 200 includes retractor for retracting tissue into range of first arm 202 and second arm 204.
  • Endoluminal surgical device 100, end effecter 200, and anchor object 220 are further disclosed in the referenced patent publications and patent applications incorporated herein by reference.
  • anchor object can be constructed from any biocompatible material, such as, but not limited to, stainless steel, cobalt chromium, titanium, alloys of such metals, biocompatible polymers, soluble polymers, non-soluble polymers, swellable polymers, absorbable polymers, suture material, bioresorbable suture, bioabsorbable suture, combinations thereof, or the like.
  • endoluminal surgical device 100 is utilized to manipulate tissue 320 of a hollow organ, such as for example the stomach, and form plications, such as plication Pl .
  • Plication Pl is formed by gathering or manipulating tissue 320 of the wall of the organ with end effecter 200 into a fold and piercing the folded tissue 320 with needles 206 of end effecter 200. As needles 206 pierce the tissue of the first plication Pl, suture material 312 is pushed through the tissue and first pledget 222 is deployed. According to an embodiment, one end of suture 312 is attached to pledget 222 and the other end of suture 312 remains free and outside the patient. According to an alternative embodiment, both ends of suture 312 remain free and outside the patient's body. Pledget 222 can be loosely attached or securely attached to suture 312 by a knot, a suture clip, being integral with suture 312, combinations thereof, or the like.
  • second pledget 224 is preferable positioned with respect to suture 312 outside the body and introduced into the hollow organ with endoluminal device 100.
  • Second pledget 224 is then moved into the hollow organ and endoluminal device 100 is manipulated to form a second fold of tissue or plication P2.
  • Second plication P2 is then pierced with needle 206, thereby pushing suture 312 through plication P2 and bringing second pledget 224 into position adjacent a side of plication P2.
  • suture 312 is tightened such that plication Pl and plication P2 are drawn together.
  • pledget 222 and pledget 224 are positioned on opposing sides of plication Pl and P2, respectively.
  • second pledget 224 are positioned on the same side of plication Pl and plication P2, respectively.
  • suture 312 is fixed.
  • suture 312 can be either removably fixed or irremovably fixed to hold plication Pl and plication P2 in position.
  • Suture 312 can be fixed with a knot, a suture clip, fused together, combinations thereof, or the like.
  • a predetermined pressure can be applied through the tightening of suture 312 such as to generate a predetermined treatment condition between the plications. According to some embodiments, this procedure is performed in the stomach of a patient.
  • plication Pl and plication P2 are formed approximately 2 cm from gastro-esophageal junction (GEJ) 310. According to alternative embodiments, plication Pl and plication P2 are formed between about 2 cm and about 5 cm from GEJ 310.
  • pledgets 222 and 224 may or may not be used to form plications Pl and P2, respectively. It should be appreciated that depending on a condition to be treated, tissue type being treated, location of treatment, size or area to be treated, combinations thereof, and the like, pledgets 222 and 224 may not be necessary, thereby, simply using suture 312 to form plications Pl and P2 and tighten plications Pl and P2 together.
  • a patch 318 can be introduced with endoluminal device 100 into the organ to be treated. Patch 318 can be associated with a tissue engaging portion of the device and placed on the wall of the organ 320 when the tissue engaging portions grasp the wall to form the plication. In some embodiments, patch 318 is coupled with a plication, such as plication P2, through pledget 224. According to alternative embodiments, patch 318 can be attached at a plurality of locations to the wall of the organ. Patch 318 can increase the integrity of the organ. In some embodiments, patch 318 includes therapeutic agents such as, for example, antibiotics, drugs, inhibiting agents, anti-inflammatory agents, combinations thereof, and the like. The therapeutic agents can 2006/046026
  • patch 318 can include a medical treatment such as, but are not limited to, PPI/H2 blockers associated with the medical implant; electrodes for gastric stimulation/electrical blockage of contraction; pain medication; cardiac medication, antihypertensives agents, insulin, hypoglycemic agents, and the like; antipsychotic medications; birth control medications; pH sensor with or without antacid secretion; GPS-like locator for people who get lost (e.g., Alzheimer's, etc.); vascular sensor for oxygen, carbon dioxide, glucose, blood pressure, and the like; sensor for defibrillation; cardiac rate/rhythm sensor that can stimulate vagus nerve to increase heart rate if necessary; combinations thereof; and the like.
  • a medical treatment such as, but are not limited to, PPI/H2 blockers associated with the medical implant; electrodes for gastric stimulation/electrical blockage of contraction; pain medication; cardiac medication, antihypertensives agents, insulin, hypoglycemic agents, and the like; antipsychotic medications; birth control medications; pH sensor with or without
  • patch 318 can be implanted onto tissue 320 with multiple attachments.
  • patch 318 can be located or held in position by coupling retractors 404A - 404D to tissue 320 and/or patch 318.
  • implant 318 may be such a shape or dimension that multiple anchor objects 220 are required for proper or secure attachment of implant 318 to tissue 320.
  • multiple anchors 408A - 408D are implanted through tissue 320 and implant 318 to affix implant 318 as desired to tissue 320.
  • anchors 408A - 408D include pledgets, such as pledgets 222 and 224 and suture 226.
  • implant 318 can be, but is not limited to, a drug delivery device, such as for example a delayed delivery material, delayed absorbable drug eluding material, selectively drug permeable material or membrane, time release delivery device, combination thereof, or the like.
  • implant 318 can be, but is not limited to a stimulator device, such as for example, an electrical stimulation device, mechanical stimulation device, vibratory device, sound stimulation device, ultra-sound stimulation device, combinations thereof, or the like.
  • the stimulation device can be configured to stimulate a sense of a patient.
  • the sense stimulated by the stimulation device can be a sense of satiety in the patient such that the patient's desire for eating is subsided.
  • implant 318 can be, but is not limited to, a sensory device, such as for example, a device to monitor pH, pressure, temperature, salinity, hydration, cellular activity, protein levels, glucose levels, insulin levels, hormone levels, biological function, biological secretion, cellular uptake, cellular secretion, combinations thereof, and the like.
  • implant 318 can be, but is not limited to, a device to control biological activity, such as for example, inter or intra cellular pH, temperature, salinity, cellular function, cellular excretion, cellular uptake, glucose levels, insulin levels, combinations thereof, and the like.
  • suture 226 can be resorbable suture material or non-resorbable suture material.
  • implant device 318 is shown implanted with respect to tissue 320 of a patient.
  • tissue 320 can be stomach wall tissue 604 and stomach mucosa 602 and formed into plication 620.
  • Plication 620 is affixed with an anchor object that includes pledgets 222 and 224.
  • pledgets 222 and 224 can be coupled together with a tee bar 608 and suture 226 and in other embodiments pledgets can be coupled together with suture 226.
  • implant 318 can be integral with pledget 224, coupled with pledget 224, or removable coupled with pledget 224.
  • the coupling between pledget 224 and implant 318 can be degradable over a predetermined time such that implant 318 can become detached from pledget 224.
  • implant 318 can be any of the implant devices, sensors, drugs, drug delivery devices, monitors, control devices, combinations thereof, and the like that are described herein and/or incorporated into this application by reference.
  • end effecter 200 is shown having first arm 202 configured to couple with implant 318.
  • Implant 318 further includes an affixing portion 716 for engaging with needle 206 and coupling thereto to bind tissue therebetween.
  • implant 318 can be any of the implant devices described herein or incorporated herein by reference.
  • suture 226 and pledget 224 can be fabricated according to other embodiments described herein or incorporated herein by reference. T/US2006/046026
  • a plication 820 can be formed from a tissue wall or lining 320.
  • Plication 820 is formed from binding tissue 320 with an anchor object that includes pledgets 222 and 224.
  • pledgets 222 and 224 can be coupled with suture 226 and tee bar 808.
  • implant 318 can be implanted with anchor object by coupling implant 318 between tissue wall 320 and pledget 222.
  • the tips of needles 206 are configured to break upon activation of the device 100, and thereby form suture retaining t-bars as described in more detail herein.
  • implant 318 can be implanted on a tether 916 such that implant 318 is relatively affixed to tissue but not rigidly affixed to any particular tissue.
  • needle 206 of second arm 204 includes suture 226 attached with pledget 224 for affixing tissue into a plication and suture 226 extends further beyond pledget 224 and couples with implant 318.
  • implant 318 is implanted into a patient and affixed into a general location, however, implant 318 is semi-free to move within patient to the extent of tether 916 provided between pledget 224 and implant 318.
  • FIG. 10 shows tethered implant 318 in an implanted position with respect to a tissue plication 1020.
  • tether 916 can be an extension of suture material 226 used to secure the anchor object.
  • anchor implant 220 includes a coupling 1102 and pledgets 222 and 224 coupled together by suture 226.
  • Anchor implant 220 is configured to couple tissue 320 to itself or to an implanted device.
  • coupling 1102 is configured to provide a site on anchor implant 220 for attaching an implantable device, mechanical tool, drug eluding device, sensor, other device described or incorporated herein, combinations thereof, or the like.
  • coupling 1 102 can be, but is not limited to a hook, clip, Vclcro, magnet, loop, combinations thereof, or the like.
  • coupling 1102 can be formed from a non-resorbable polymer, resorbable polymer, biodegradable polymer, drug eluding polymer, stainless steel, titanium, cobalt chromium, surgical material, combinations thereof, or the like.
  • end effecter 200 is used to form a first plication 1206.
  • Plication 1206 is formed by grasping tissue with retractor 1214 and manipulating first arm 202 and second arm 204 together such that needle 206 pierces the tissue.
  • Suture 226 is associated with needle 206 such that suture 226 is pierced through tissue with needle 206.
  • suture 226 is positioned through a hole in needle 206, as described herein, such that a quantity of suture material 226 forms a barb on one side of needle 206 (shown in FIG. 31).
  • the barb can function to hold tissue on needle 206 after needle 206 has been penetrated through a first quantity of tissue.
  • the barb can be a loop of suture material 226, a knot tied in suture material 226 on one side of needle 206, or the like.
  • retractor 1214 is used a second time to grasp a second portion of tissue to form second plication 1302.
  • an open pocket 1304 is formed therebetween.
  • an implant 1306 is housed in open pocket 1304.
  • end effecter 200 can have multiple retractors 1214 such that two plications can be formed simultaneously.
  • a first retractor can grasp tissue and form a first plication while a second retractor grasps other tissue and forms a second plication.
  • the two plications can be anchored together such that an open pocket 1304 is formed therebetween.
  • tissue graspers are introduced into the surgical site percutaneously for grasping tissue and manipulating it into adjacent plications that form the tube or open pocket 1304.
  • the tissue graspers pull tissue around the flexible shaft 102 of the surgical device 200 and position the tissue for implantation of the anchor object.
  • an anchor object is implanted to fasten the plications around the shaft of the surgical device.
  • the end effecter 200 is straightened such as to be axially aligned with shaft 102 and the shaft 102 and end effecter 200 are removed through the open pocket 1304 of the tissue plications.
  • tissue 320 that forms an open pocket 1304 between plications 1206 and 1302 may be tissue that requires treatment.
  • implant 1306 positioned in pocket 1304 is configured to treat tissue 320.
  • tissue 320 can be removed following the double plication procedure described with respect to FIGS. 12-14.
  • tissue 320 may dissolve or resorb following the double plication procedure.
  • multiple double plication procedures such as the double plication procedure described with respect to FIGS. 12-14 can be performed on adjacent tissue, in the same organ, or the like.
  • axially aligned double plications 1440, 1442, 1444, and 1446 can be positioned adjacent to each other such that each open pocket 1304, formed between the double plications 1440, 1442, 1444, and 1446, is generally axially aligned and forms an artificial biological tube 1450.
  • artificial biological tube 1450 is formed by drawing each double plication together.
  • each plication 1440, 1442, 1444, and/or 1446 can be drawn together using surgical glue, suture material, surgical wire, staples, scoring the tissue such that the tissue reforms together, combinations thereof, or the like.
  • linearly aligned double plications 1440, 1442, 1444, and 1446 are positioned, beginning at or distally near the gastro-esophageal-junction (GEJ) 1452 and extend into the stomach, thereby forming an artificial GEJ or gastric tube 1450.
  • GEJ gastro-esophageal-junction
  • the artificial gastric tube when the artificial gastric tube is flaccid, i.e., empty, the artificial gastric tube acts as a gastric flap or valve for protecting the esophagus from gastric fluids.
  • the formation of such an artificial gastric tube can be a treatment for gastroesophageal reflux disorder (GERD).
  • the formation of an artificial gastric tube can be a technique for gastric reconstruction or reduction surgery.
  • the formation of such an artificial gastric tube effectively reduces the volume of the stomach of a patient, and thereby, stimulates the stomach into providing a sense of satiety with consumption of a smaller amount of food.
  • the gastric tube forms a sleeve gastroplasty by fixing tissue of the anterior wall to the posterior wall on the lesser curve or proximal stomach, such that when food passes through the sleeve and the sleeve stretches the sensation of fullness or satiety is induced.
  • between 1 and about 10 plications are positioned adjacent each other to form artificial tube 1450.
  • between 1 and about 8 plications are positioned adjacent each other to form artificial tube 1450.
  • between 1 and about 5 plications are positioned adjacent each other to form artificial tube 1450.
  • between 1 and about 3 plications are positioned adjacent each other to form artificial tube 1450.
  • a single plication is positioned adjacent the GEJ to form artificial tube 1450 or GERD treatment.
  • between about 5 and about 8 plications are positioned adjacent each other to form artificial tube 1450.
  • artificial tube 1450 when artificial tube 1450 is formed with between one and two tissue plications, artificial tube 1450 is about 1 cm in length. In other embodiments, when artificial tube 1450 includes between about 10 to about 20 tissue plications, artificial tube 14550 is about 10 cm in length. In some embodiments, the diameter of artificial tube 1450 is between about 0.2 cm and about 10 cm. In other embodiments, the diameter of artificial tube 1450 is between about 0.5 cm and about 5 cm. In some embodiments, the diameter of artificial tube 1450 is between about 0.5 cm and about 3 cm. In some embodiments, the diameter of artificial tube 1450 is between about 0.5 cm and about 2 cm.
  • linear placement of multiple plications 1440, 1442, 1444, and 1446 can be utilized to close an incision in a tissue wall, such as for example, following abdominal or thorasic surgery accessed through the gastric wall, colon, intestine, or esophagus as in N. O. T. E. S. procedures.
  • a distal end 90 of the endoscope device is shown.
  • Distal end 90 includes needles 91 and 92 which include holes 88 for receiving suture material.
  • needles 91 and 92 each receive separate suture material 94 and 96, respectively.
  • suture 94 is looped through needle 91 and is secured through a pair of openings 102 in pledget 222.
  • suture 96 is looped through the second needle 92 and passes through a third hole 103 in pledget 222.
  • pledget 222 is positioned with respect to a plication and suture 94 and 96 is pierced through the plication. The free end of suture 96 extends outside of the patient's body for receiving a second pledget as described herein.
  • FIG. 17 shows another embodiment of the present invention, wherein suture 94 and 96 both loop through pledget 222, through their respective needles 91 and 92 of distal end 90 and extend out of the patient's body for further manipulation.
  • FIG. 18 shows a knot pusher 110 that can be utilized to tighten and secure suture 226 affixed between plications.
  • the present invention also discloses methods for restricting a hollow organ. Referring to FIG. 19, a single suture crisscross loop is shown. Plications Pl and P2 are formed similar to the methods described with respect to FIG. 3 and elsewhere herein, however, suture 226 is crossed.
  • plications Pl and P2 are twisted or rotated during tightening of suture 226.
  • twisting or rotation of plications Pl and P2 result in a predetermined interface between plications Pl and P2.
  • plications Pl and P2 are formed similar to those described with reference to FIG. 3, however, each plication Pl and P2 is formed with a pledget 222 and 224, respectively, attached to an independent loop of suture 226 and 227, respectively. According to methods using individual suture loops
  • each plication can be tightened independently of the other. Therefore, each plication Pl and P2 can be tightened and treated independently as needed, then plications Pl and P2 can be brought into contact with each other and subjected to a third independent tightening when suture loop 226 and
  • methods of the present invention also include forming plications Pl and P2 through the use of straight strands of suture material.
  • pledget Pl is formed by manipulating tissue into a fold and piercing the tissue with needle 206 and suture 226 affixed to pledget 222.
  • plication P2 is formed by manipulating tissue into a fold and piercing through the fold with suture 227 attached to pledget 224. After formation of plication Pl and P2, suture 226 and suture 227 are tightened such that plications Pl and P2 are approximated together.
  • pledgets 222 and 224 can be positioned on similar sides of plications Pl and P2 or on opposing sides. Pledgets positioned on opposing sides of plications Pl and P2 are shown in FIG. 22. Approximating plications Pl and P2 together reduces the volume of the hollow organ, such as the stomach, as shown in FIG. 26.
  • plications Pl and P2 are affected with resections 66 and 68, respectively.
  • Resections 66 and 68 can be, but are not limited to, intentional tissue resections, resection from removal of a tumor, fistulas, resection from removal of necrotic tissue, combinations thereof, and the like.
  • plications Pl and P2 are formed, as described in any of the methods described herein.
  • suture 226 and pledgets 222 and 224 are positioned such that when suture 226 is tightened, resections 66 and 68 of plications Pl and P2, respectively, will be brought into contact with each other.
  • Methods such as these presently described methods assists in healing of plications Pl and P2 together following their approximation. Therefore, in such embodiments, suture 226 and pledgets 222 and 224 can be absorbable, such that they are dissolved by the body tissue after a predetermined implant period.
  • suture 226 and pledgets 222 and 224 can be nonabsorbable, and the healing of resections 66 and 68 to each other provides additional support to the adjoined plications.
  • multiple plications, Pl, P2, P3, and P4 can be formed with a single suture 226. All plications P1-P4 will be drawn together upon tightening of suture 226.
  • a hollow organ such as the stomach for example, can be approximated together in a uniform manner.
  • FIGS. 25 A and 25B other embodiments of the present invention include methods of forming multiple plications P1-P4 with multiple suture 226 and 227.
  • plications P1-P4 are formed in accord with methods described herein, however, plications P 1 and P2 are connected with suture 226 and plications P3 and P4 are connected with suture 227, which is independent from suture " 226 ⁇ FfG " 2lA " sliovvs ⁇ sutures T26 andT27 Implanted but not tightened and FIG ⁇ 25B shows the tissue after the plications P1-P4 are tightened.
  • FIG. 25B shows the tissue after the plications P1-P4 are tightened.
  • plications Pl and P3 are formed with suture 226 threaded there through with pledgets 2521 and 2523, respectively, abutting plications Pl and P3.
  • Plications P2 and P4 are formed with suture 227 threaded there through with pledgets 2522 and 2524, respectively, abutting the plications P2 and P4.
  • suture 226 can be tightened such that plication Pl and P3 are brought into position adjacent each other with pledgets 2521 and 2523 on opposite sides of their respective plications.
  • suture 227 can be tightened such that plication P2 and P4 are drawn together resulting in pledgets 2522 and 2524 being on opposite of their respective plications.
  • plications Pl and P3 can be formed at a first distance from GE junction 10 and plications P2 and P4 can be formed at a second distance from GE junction 10. According to such embodiments, when plications Pl and P3 are approximated together and plications P2 and P4 are approximated together, the respective plications do not interfere with each other and the hollow organ can be reduced to a predetermined size. According to some embodiments, a distance is left between the sets of plications.
  • hollow organ 2600 is configured with a restricted pouch 2602 via a restriction 2604.
  • hollow organ 2600 can be a stomach for example, and restriction 2604 can function as a gastric reduction procedure for treating obesity for example.
  • tissue grasper 2700 is shown configured to be used in association with endoluminal device 100.
  • Tissue grasper 2700 includes a proximal end 2702 that remains outside a patient's body and is configured to be operated by a surgeon or other medical provider.
  • Proximal end 2702 includes a slidable member 2704 which US2006/046026
  • Slidable member 2704 also includes graspable portions such as rings 2712 and 2714.
  • a flexible shaft 2720 extends from proximal end 2701 and connects the proximal ' end ' 2702 " with " dfstai end 27227 Hexib ⁇ Thaft " 2720 includes an outer housing 2722lhat is configured to house inner rod 2708.
  • Flexible shaft 2720 can be, for example, a flexible metal coil or plastic housing.
  • Preferably flexible shaft 2720 is compatible with biological solutions and tissues such that flexible shaft 2720 is not degraded or affected by interaction with the biological solutions or tissues.
  • distal end 2724 of flexible shaft 2720 includes a rigid receiver 2730 and graspers 2726 and 2728.
  • Rigid receiver 2730 forms the distal most portion of flexible shaft 2708 and includes a longitudinal opening through which inner rod 2708 and/or graspers 2726 and 2728 can pass.
  • Graspers 2726 and 2728 couple with or are integral with inner rod 2708 on a proximal end and are angled or hooked on a distal working end to form tissue hooks 2727, 2729 to grasp tissue.
  • Graspers 2726 and 2728 are fabricated from flexible material such that graspers 2726 and 2728 can flex and be approximated together. Graspers 2726 and 2728 further include tissue hooks 2727 and 2729, respectively, for attaching to tissue.
  • graspers 2726 and 2728 are fabricated from a polymer based material, a metal, combinations thereof, or the like. According to a preferred embodiment, graspers 2726 and 2728 are fabricated from memory metal such as nickel-titanium alloys.
  • tissue to be treated is appropriately retracted and approximated with the tissue grasper 2700
  • the medical provider then activates end effecter 200 which engages first ami 202 with second arm 204, piercing the tissue with the needles and suture, deploying the anchor implant and thereby retaining tissue in the approximated position.
  • end effecter 200 engages first ami 202 with second arm 204
  • piercing the tissue with the needles and suture deploying the anchor implant and thereby retaining tissue in the approximated position.
  • the user pushes rings 2712 and 2714 distally, thereby moving graspers 2726 and 2728 distally, relaxing the grasped tissue and releasing it from tissue hooks 2727 and 2729.
  • tissue grasper 2700 can be used independently of endointernal surgical device 100 such as through a trocar/cannula surgical port.
  • the tissue grasper 2700 is used in combination with endoluminal surgical device 100 and introduced endoluminally into the lumen of an organ needing treatment, such as shown in FIG. 29.
  • End effecter 200 includes a port 2902 between first arm 202 and second arm 204 through which distal end of tissue grasper 2700 passes. Therefore, in use, when tissue is retracted and approximated with tissue hooks 2727 and 2729 the tissue is positioned within the proper working space of first arm 202 and second arm 204 for implantation of a tissue anchor as described herein.
  • the tissue grasper 2700 can be used through an opening in an endoscope or along side the endoluminal surgical device or endoscope.
  • Methods of using the tissue graspers 2700 include approximating two portions of tissue that are between about 2 centimeter and about 5 centimeter and need to be approximated before end effecter 200 can effectively deploy the anchor implant.
  • the tissue grasper 2700 also help present full tissue thickness, such as for example stomach mucosa and muscle tissues to the end effecter 200 for secure implantation of the anchor object.
  • the total length of the tissue grasper 2700 is about 50 inches, the graspers 2726 and 2728 open about 1.5 inches wide, and the graspers are about 0.030 inches in diameter.
  • tissue graspers 2700 can be used during procedures where tissue of an organ wall is resected, e.g. , to removal of a mass or damage in the tissue. During such procedures, perforation of the organ wall can occur, thereby, resulting in an opening in the organ wall that needs closure. The tissue grasper 2700 can then be used to bring together opposite edges of the perforation before deploying an anchor implant to close the opening. Other procedures the tissue grasper 2700 can be useful in includes restructuring of gastric bypass procedures, such as a ROUX-en- Y procedure.
  • tissue grasper 2700 will be useful in bring together opposite edges of such an anastomosis or pouch before deploying an anchor implant to Fix the tissue.
  • tissue grasper 2700 can be useful in bring together opposite edges of such an anastomosis or pouch before deploying an anchor implant to Fix the tissue.
  • Yet another procedure in which tissue grasper 2700 can be useful includes a NOTES (Natural Orifice Transluminal Endoscopic Surgery) procedure in which an incision is made in the stomach, colon, or other orifice to facilitate passage into the abdominal or thorasic cavity.
  • the tissue grasper 2700 will be useful in bring together the opposite edges of the incision through which the NOTES procedure passed for entry into the abdominal or thorasic cavity.
  • Needle 206 generally includes holes 88 for receiving suture material, a tissue piercing distal tip 3004, and a scored section 3002. Holes 88 are configured to receive suture material 312, as shown in FIG. 31.
  • the scored section 3002 is configured to break after needle 206 is passed through pledget 222 or 224 when first arm 202 is approximated with second arm 204.
  • a deflector in second arm 204 deflects the distal tip 3004 of needle 206, which causes the distal tip 3004 to break at scored section 3002.
  • distal tip 3004 acts as a T-bar restricting suture material 312 from reversibly passing through the pledget and thereby anchoring tissue between the pledgets 222 and 224.
  • suture 312 is positioned through hole 88 such that a quantity of suture material forms a barb 3102 of suture material on one side of needle 206, as shown in FIG. 31.
  • Barb 3102 can function to hold tissue on needle 206 after needle 206 has been penetrated through a first quantity of tissue, such as described with 6 046026
  • Barb 3102 can be a loop of suture material 312 such as shown in FIG. 31 or a knot tied in suture material 312 on one side of needle 206 or the like.
  • FIGS. 32, 33, and 34 methods and devices for tightening an anchor implant are shown.
  • a pledget based implant as shown in FIG. 32 can be implanted to close an incision, such as incision 3202 in tissue.
  • the tissue having the incision or damage to be closed is brought together as a plication with the endoluminal surgical device 100, as described herein.
  • suture material 312 couples pledget 222 with pledget 224 and is bound on one side of pledget 222 with distal needle tip 3004.
  • the other end of suture material 312 can include a slip knot 3200 that can remain loose after implanting pledgets onto the tissue and then be tightened to a selected tension when appropriate, such as following completion of the NOTES procedure.
  • a suture clip such as suture clip 3300 can be used to tighten suture 312 onto tissue to be closed.
  • FIGS. 33 and 34 show a suture clip 3300 having biasing arms 3302 configured to engage suture material 312 and maintain pressure against tissue to be approximated or closed.
  • Example 1 Endoscopic fistula repair using full-thickness plication in the porcine stomach model.
  • Iatrogenic gastric perforations and fistulae often require surgical repair.
  • a durable endoscopic alternative to surgical repair is desirable.
  • an endoscopic technique is developed and evaluated to repair an iatrogenic gastric perforation using the Full-Thickness Plicator® (NDO Surgical, Mansfield, MA) in the porcine stomach model. 46026
  • Laparoscopic gastric banding has been successful in treating morbid obesity.
  • the following example provides an endoscopic creation of a restrictive gastric pouch.
  • a durable restrictive gastric pouch was generated endoscopically in a porcine stomach model using the Full-Thickness Plicator® (NDO Surgical, Mansfield, MA).
  • Five ex-vivo porcine stomachs were used in this study.
  • a plicator implant was threaded with a 2-0 polypropylene suture through the holes of one of the pledgets of the implant to form a long U-shaped suture. The plicator was loaded with an implant and passed endoluminally into the stomach.
  • the anterior/fundal gastric wall roughly 2 cm below the GE junction was retracted and a full-thickness transmural plication performed.
  • the suture loop remained through the pledget with both ends of the suture extending outside of the esophagus.
  • One end of the suture was then passed through the pledget holes of a second implant.
  • the plicator was reloaded and a similar plication was performed roughly 2 cm below the GE junction at the posterior/lesser curvature gastric wall. Both ends of the sutures extended outside of the esophagus.
  • This process was repeated with a third and fourth plication at the posterior/ fundus and anterior/lesser curvature of the stomach roughly 2 cm below the GE junction.
  • the first and second plications were approximated, secured and the suture cut.
  • the third and fourth plications were approximated, secured, and the suture cut.
  • Figures 25 A and 25B show a cross-sectional schematic of the four opposing plications formed endoscopically within the stomach. After creation of the full-thickness plication locations within the stomach, the opposing plications are approximated together to create a gastric pouch, as shown schematically in Figure 26. [0097] The 4 approximated and secured full-thickness, transmural plications created a durable restrictive gastric pouch. The capacity of the pouch in all 5 porcine stomachs was consistently between about 10-15 ml with the opening diameter between about 8-10 mm.
  • Example 3 Endoscopic transmural resection of gastric wall using full-thickness plication.
  • Endoscopic mucosal resection allows removal of premalignant mucosal lesions. Lesions invading into the submucosa and muscularis basement were resected endoscopically by transmural resection of the gastric wall using the Full-Thickness Plicator® (NDO Surgical, Mansfield, MA) in the porcine stomach model.
  • Full-Thickness Plicator® NDO Surgical, Mansfield, MA
  • Five excised porcine stomachs were used in this experiment. A plicator cartridge was created with suture length of about 4 mm between the pledgets. The plicator was inserted into the stomach and the tissue retractor was extended into targeted gastric wall.
  • the gastric cardia was retracted into the open arms of the plicator and a full- thickness plication was created to allow serosa to serosa contact.
  • a stiff snare was used to resect the plicated gastric wall above the implant using electrocautery. The serosa to serosa tissue union was left intact.
  • the excised wall was examined to ensure a full- thickness resection and the size was measured. The integrity of the plication was tested by instilling a colored, carbonated liquid to distend the stomach.
  • a transmural, full- thickness gastric wall resection was achieved in all 5 porcine stomachs.
  • the diameter of the excised specimen ranged from about 2 cm to about 3 cm.
  • the gastric wall was securely closed with no leaks observed after the full-thickness resection was performed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgical Instruments (AREA)

Abstract

L’invention a pour objet un dispositif thérapeutique endoluminal et un procédé comprenant l’introduction d’un dispositif endoluminal dans une lumière corporelle et la mise en prise d’une paroi de la lumière avec un écarteur du dispositif endoluminal. La paroi est rétractée de manière à ce que les surfaces extérieures de la lumière entrent en contact l’une avec l’autre et forment une plicature. Le dispositif est ensuite manœuvré pour mettre en place un système fixant la plicature en toute sécurité. Plusieurs plicatures peuvent être réalisées dans la paroi de l’organe et rapprochées afin de réduire le volume de la lumière et de former une poche comme lors d’une réduction gastrique.
EP06838801A 2005-12-01 2006-12-01 Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire Withdrawn EP2004243A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74151005P 2005-12-01 2005-12-01
US84941406P 2006-10-04 2006-10-04
PCT/US2006/046026 WO2007064906A2 (fr) 2005-12-01 2006-12-01 Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire

Publications (2)

Publication Number Publication Date
EP2004243A2 true EP2004243A2 (fr) 2008-12-24
EP2004243A4 EP2004243A4 (fr) 2009-12-16

Family

ID=38092835

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06838801A Withdrawn EP2004243A4 (fr) 2005-12-01 2006-12-01 Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire

Country Status (2)

Country Link
EP (1) EP2004243A4 (fr)
WO (1) WO2007064906A2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US8333776B2 (en) 2005-05-20 2012-12-18 Neotract, Inc. Anchor delivery system
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9034001B2 (en) 2005-05-20 2015-05-19 Neotract, Inc. Slotted anchor device
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US8425535B2 (en) 2005-05-20 2013-04-23 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8834492B2 (en) 2005-05-20 2014-09-16 Neotract, Inc. Continuous indentation lateral lobe apparatus and method
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US9364212B2 (en) 2005-05-20 2016-06-14 Neotract, Inc. Suture anchoring devices and methods for use
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US9149266B2 (en) 2005-05-20 2015-10-06 Neotract, Inc. Deforming anchor device
US8394113B2 (en) 2005-05-20 2013-03-12 Neotract, Inc. Coiled anchor device
US8529584B2 (en) 2005-05-20 2013-09-10 Neotract, Inc. Median lobe band implant apparatus and method
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
WO2008085290A2 (fr) 2006-12-28 2008-07-17 Vibrynt, Inc. Dispositifs et méthodes de traitement de l'obésité
US8092474B2 (en) 2007-05-21 2012-01-10 Ethicon Endo-Surgery, Inc. Methods and devices for placement of an intra-abdominal or intra-thoracic appliance through a natural body orifice
EP2280653A2 (fr) 2008-04-22 2011-02-09 Ethicon Endo-Surgery, Inc. Procédés et dispositifs permettant d'orienter des outils chirurgicaux
CA2721462C (fr) * 2008-04-25 2019-02-05 Zymogenetics, Inc. Dispositifs medicaux pour administrer des fluides pendant une chirurgie et leurs procedes d'utilisation
US8834495B2 (en) * 2008-06-30 2014-09-16 Arthrocare Corporation Independent suture tensioning and snaring apparatus
JP2012205676A (ja) * 2011-03-29 2012-10-25 Terumo Corp センサ
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
WO2019126718A1 (fr) 2017-12-23 2019-06-27 Neotract, Inc. Appareil et procédé de mise en prise de tissu extensible
US20220031358A1 (en) 2020-08-03 2022-02-03 Neotract, Inc. Handle and cartridge system for medical interventions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020138086A1 (en) * 2000-12-06 2002-09-26 Robert Sixto Surgical clips particularly useful in the endoluminal treatment of gastroesophageal reflux disease (GERD)
US7149587B2 (en) * 2002-09-26 2006-12-12 Pacesetter, Inc. Cardiovascular anchoring device and method of deploying same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO2007064906A2 *

Also Published As

Publication number Publication date
WO2007064906A3 (fr) 2009-06-11
WO2007064906A2 (fr) 2007-06-07
EP2004243A4 (fr) 2009-12-16

Similar Documents

Publication Publication Date Title
WO2007064906A2 (fr) Dispositifs et procedes endoluminaux de restriction gastrique et manipulation tissulaire
US8209037B2 (en) Methods and devices for medical treatment
US7841978B2 (en) Methods and devices for to treatment of obesity
US8551118B2 (en) Hybrid endoscopic/laparoscopic method for forming serosa to serosa plications in a gastric cavity
US8409226B2 (en) Method of performing transgastric ventral hernia repair and tissue anchors and deployment devices therefor
US8556934B2 (en) Article, system, and method for securing medical devices to treat obesity, gastro-esophageal reflux disease (GERD) and irritable bowel syndrome (IBS) reversibly
US10350050B2 (en) Method for gastric volume reduction surgery
US20060235446A1 (en) Article, system, and method for securing medical device to tissue or organ
US20090024144A1 (en) Hybrid endoscopic/laparoscopic device for forming serosa to serosa plications in a gastric cavity
US20060264699A1 (en) Extragastric minimally invasive methods and devices to treat obesity
US20090023984A1 (en) Device for insufflating the interior of a gastric cavity of a patient
EP2306942B1 (fr) Réduction de volume gastrique au moyen de jonctions de parois antérieure et postérieure
US20110106129A1 (en) Methods and devices to treat obesity
JP2011519625A (ja) 患者の胃腔内部にガスを注入するための装置
US20090024077A1 (en) Method of insufflating the interior of a gastric cavity of a patient.
Swain Endoscopic suturing
JP2009082692A (ja) 患者の胃腔内部にガスを注入するための装置
WO2010005436A1 (fr) Procédure bariatrique restrictive percutanée très peu invasive et dispositif associé

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20090611

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 17/08 20060101ALI20090811BHEP

Ipc: A61B 17/10 20060101AFI20090811BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091116

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 17/04 20060101AFI20091110BHEP

17Q First examination report despatched

Effective date: 20100304

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130702